US Omega-3 Sales Expected To Grow Nearly 6% As Less ‘Mature’ Markets Accelerate
Executive Summary
US and Europe led in 2019 sales of omega-3-fortified products worldwide, a market valued at $44bn that has extended beyond supplements and baby formulas to include foods, beverages and pet food, says GOED in report released 26 May. As the US market is ‘mature,’ its sales growth is expected at 5.8% in 2021, while sales of less mature markets such as Asia (excluding China) is anticipated to climb 12.6%.
You may also be interested in...
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Largest Meta-Analysis Suggests Higher Omega-3 Doses For Heart Health
Omega-3 supplementation results in 8% reduction in heart attack and coronary heart disease risk over a five-year period versus placebo, finds a meta-analysis in JAMA. Encompassing 120,000 patients, research updates recent meta-analyses with addition of three studies in past year, two casting doubt on heart health benefits of omega-3s.
Omega-3 Heart Health Claims Decision: FDA Out Of Step With Industry?
"The reality is that the FDA remains unwilling to rely upon a meta-analysis of only the highest quality studies in order to guide its final decision," GOED VP Harry Rice. "I think FDA has really lost sight of how the dietary supplement industry has changed," says attorney Charles Jolly.